Analyst firms · Raymond James · CI
Raymond James CI price target and rating history
The Cigna Group (CI) · Health Care
Raymond James rates The Cigna Group (CI) Outperform with a $320 price target, as of its latest action on Aug 3, 2026. It has published 4 rating actions on CI since August 2021, including 1 upgrade and 2 downgrades. Across 6 firms with a CI price target in the last 12 months, the median target is $305.50. Raymond James's $320 is 5% above that.
- Current rating
- Outperform
- Price target
- $320
- Median target, all firms
- $305.50
- Actions on CI
- 4
Raymond James price target on CI
Every Raymond James rating on CI
- Aug 3, 2026
- Apr 5, 2023
- Nov 21, 2022
- Aug 9, 2021
How other firms rate CI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Evercore ISI | In-line | $290 | Sep 9, 2026 |
| Jefferies | Hold | $307 | Aug 4, 2026 |
| Raymond James | Outperform | $320 | Aug 3, 2026 |
| Barclays | Equal Weight | $304 | May 26, 2026 |
| Deutsche Bank | Hold | $302 | May 20, 2026 |
| Bernstein | Outperform | $358 | Mar 12, 2026 |
Questions about Raymond James and CI
- What is Raymond James's price target for CI?
- Raymond James's latest stated price target for The Cigna Group (CI) is $320, from its action on Aug 3, 2026.
- What is Raymond James's rating on CI?
- Raymond James rates CI Outperform, a bullish rating, as of Aug 3, 2026.
- When did Raymond James last change its view on CI?
- On Aug 3, 2026, Raymond James downgrades to Outperform from Strong Buy, price target $320.
- How does Raymond James's CI target compare with other analysts?
- Across 6 firms with a CI price target in the last 12 months, the median target is $305.50. Raymond James's $320 is 5% above that.
More CI rating histories
All Raymond James ratingsCI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.